DaVita Inc. (DVA) Balance Sheet

The deterioration appears driven by sustained buybacks that have consumed equity faster than retained earnings have rebuilt it, even as quarterly earnings turned positive. This pattern suggests the balance sheet is weakening structurally rather than cyclically, and investors should monitor whether earnings growth can outpace repurchase-driven equity erosion. The trajectory warrants further investigation into how much of the debt increase is funding repurchases versus operations.

With total liabilities of $16.7 billion against total assets of $17.8 billion, the company carries little margin between asset value and obligations. Such leverage may limit flexibility if interest rates remain elevated or if operating cash flow softens. Refinancing terms and the fixed versus floating rate mix are not disclosed in the supplied data, so the exposure cannot be fully assessed.

The concentration in property and goodwill is consistent with a capital-intensive dialysis facility model that depends on physical density and past acquisitions. Goodwill at this scale carries impairment risk if facility-level cash flows weaken under reimbursement pressure. The stability of PP&E across the period suggests maintenance rather than rapid expansion.

Cash fell from $1.1 billion in 2024Q3 to $495.6 million, reducing the margin available to absorb shocks such as a labor cost spike or a reimbursement shortfall. The current ratio above 1.0 indicates near-term obligations are covered on paper, but the modest cash position limits operational flexibility. Liquidity appears adequate for routine operations yet sensitive to any deterioration in cash generation.